
Amazon Deals of the Day: This 50% Discount Brings These Anker Earbuds to Just $20
Today, we found the already affordable Anker earbuds at 50% off, bringing them back to their record-low price. We also caught the VTech baby monitor for only $5 more than its record-low price. And lastly, we spotted the Feierdun adjustable dumbbells for a nice $50 off, also down to a record low.
Just about all of us use wireless earbuds in some capacity, so having a solid pair is pretty important. But a good pair doesn't have to cost you hundreds of dollars. The Soundcore by Anker P20i earbuds are a great pick, one that I personally use regularly. These earbuds have built-in microphones for making calls without all the background noise. There are also over 20 preset equalizers you can pick from to make sure you get the perfect sound for you. The battery life is lenghty as well, with one charge giving you 10 hours of battery and the case extending that to up to 30 hours. These earbuds come in multiple colors, so you can chose which one you like best.
These earbuds are normally $40, already a great price. But Anker just sliced that price in half, bringing them down to $20, a record-low price. Just keep in mind only three of the five color options, black, white and blue, are down to $20, so be mindful when picking which color you like.
Just about all parents use a baby monitor to keep eyes on their babies. But finding one that has the features you want yet also lands within your budget isn't always the easiest. VTech makes some of our favorite monitors and now you can get one for less. The VTech VM819 baby monitor is pretty compact so it can fit anywhere, plus it's also mountable so you can stick it on the wall if you need. It has two-way audio so you can speak to whoever's on the other side through the camera. Ans it has night vision as well, so you can keep eyes on your kids at night. The camera angle is also adjustable, allowing you to tilt and pan the camera as needed. It also is a great tool to keep eyes on your pets or even elderly family members if needed.
This monitor is now down to $40. Although it's only a 17% savings, it's only $5 more than the record-low price seen earlier this year. But it's still a great deal if you need something now.
If you have a home gym, you probably have some dumbbells to go with it. But buying all the weights can be pretty expensive and take up a lot of room. That's why adjustable dumbbells are more convenient. These Feierdun adjustable dumbbells can be used five different ways. You can use them as a tradition dumbbell, barbell, kettlebell, weight plate and even as a push up stand. The weight can be adjusted from six to 22 pounds. The dumbbell bar is sturdy too, as it's made of a thickened steel plate and has a non slip diamond texture. This set comes with 12 weight plates, dumbbell and barbell bars, kettlebell handles and even a kettlebell base rod.
This kit is usually $130 but for a limited time, it's down to $80. That's a nice $50 savings, not to mention a record-low price.
With so many deals on Amazon, deciding which ones are worth your money can be difficult. But CNET's combed through what the world's largest online retailer has to offer and gathered the best deals for you to check out.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
OLIVE YOUNG Brings Leading K-Beauty Brands and "All Live Young" Philosophy to KCON LA 2025 as Title Sponsor
LOS ANGELES, Aug. 1, 2025 /PRNewswire/ -- OLIVE YOUNG, South Korea's leading beauty and wellness retailer, returns as the title sponsor of KCON LA 2025, bringing its signature "All Live Young" philosophy to life through a dynamic and immersive K-beauty experience in the heart of Los Angeles. This activation marks a major milestone in the brand's journey to bring its trusted K-beauty experience to North America, with its first U.S. store set to open in Los Angeles in late H1 2026. The brand's presence at KCON reflects its commitment to making K-beauty more accessible, inclusive, and experience-driven for global audiences. At KCON LA, OLIVE YOUNG will spotlight a total of 66 brands including their award-winning private label brands—BIOHEAL BOH, BRINGGREEN, and COLORGRAM— where 164 products from 64 brands will be featured through immersive, interactive zones designed to introduce U.S. audiences to the brand's curated approach to skincare, color, and wellness. Booth Highlights Include:K-Skincare Starter Kit: "Beauty Box" Pop-Up with Global App IntegrationAs part of the pop-up experience, attendees are invited to discover OLIVE YOUNG's "Beauty Box," a curated starter kit featuring standout products from six K-beauty brands available in the U.S. assortment, including Biodance, numbuzin, and ROUND LAB. Guests who engage in the experience will have the opportunity to extend their discovery journey through the OLIVE YOUNG Global website and app, where a limited-time exclusive chance to explore a pop-up offering will be available. Core Skincare Showcase: A Glimpse into the First U.S. StoreA dedicated zone spotlights OLIVE YOUNG's four essential skincare categories—Essence & Serum, Sun Care, Sheet Masks & Pads, and Creams—offering a first look at hero SKUs likely to be included in the upcoming U.S. retail launch.. Exclusive Experience Zones: Discover OLIVE YOUNG's Private BrandsVisitors can immerse themselves in interactive brand zones from OLIVE YOUNG's top-performing private labels: BIOHEAL BOH: Explore anti-aging and lifting solutions in the BIOHEAL BOH Lab. BRINGGREEN: Get personalized skin trouble diagnosis at the BRINGGREEN Nurse's Office. COLORGRAM: Play with high-quality color at COLORGRAM's Colorful Art Room. "We're excited to bring our 'All Live Young' philosophy to life at KCON LA 2025 through curated products, thoughtful retail innovation, and a focus on experience," said Sehoon Jin, Executive Vice President of Global Platform Business at OLIVE YOUNG. "This is a meaningful step in bringing OLIVE YOUNG's trusted and inclusive K-beauty experience to the U.S. market." For more information about OLIVE YOUNG and its private label brands, visit ABOUT OLIVE YOUNG: Established in 1999, OLIVE YOUNG is South Korea's leading beauty and health retailer, dedicated to helping everyone live a healthy and beautiful life. The brand philosophy, "All Live Young," reflects OLIVE YOUNG's vision of inspiring customers to embrace wellness and beauty at every stage of life. Through its flagship store and online platforms, OLIVE YOUNG offers a curated selection of trendy and innovative K-beauty and wellness products, loved by customers worldwide. With over 1,370 stores, more than 20 years of expertise, and strong global partnerships, OLIVE YOUNG continues to set the standard for innovation, accessibility, and customer-focused retail in the K-beauty and wellness industry. As part of CJ Group, a global lifestyle company based in South Korea, OLIVE YOUNG delivers the value of healthy beauty to customers everywhere. MEDIA CONTACT: For more information and interview requests, please contact PURPLE: oliveyoung@ View original content to download multimedia: SOURCE OLIVE YOUNG Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. WASHINGTON, DC / / August 1, 2025 / MMJ International Holdings, Inc. ("MMJ") today issued a public clarification regarding prior statements about Irvine Labs, Inc., while calling for an urgent reckoning with the U.S. Drug Enforcement Administration's (DEA) catastrophic mismanagement of America's cannabis research policy. In a previous press release, MMJ referenced widespread inactivity among DEA-registered marijuana manufacturers. While these statements were intended to highlight systemic failures within the DEA's quota and licensing system, MMJ acknowledges that this language may have unintentionally caused confusion regarding Irvine Labs, Inc. MMJ hereby clarifies that Irvine Labs, Inc. is a registered DEA entity and, to the best of MMJ's current knowledge, holds valid DEA registrations. MMJ did not intend to imply that Irvine Labs is inactive or insolvent, and any interpretation suggesting otherwise is hereby retracted. This clarification, however, does not alter the underlying crisis: the DEA's marijuana manufacturing quota system is fundamentally broken. Despite a supposed expansion of DEA licenses, no registrant-except MMJ-has produced sufficient pharmaceutical-grade cannabis to support a single FDA-compliant clinical trial. The Devastating Reality: Maridose (Maine): Only 1,100 sq. ft. of space, not growing. Bright Green Corp: Surrendered its registration without ever planting a crop. Royal Emerald Pharmaceuticals: Inactive and facing financial distress. Groff NA Hemplex & Scottsdale Research Institute: No active cultivation for clinical trials. BRC: Producing quantities far below clinical thresholds. University of Mississippi: Continues to grow substandard, research-incompatible marijuana. MMJ remains the only federally compliant entity actively pursuing the cultivation of strain-specific, pharmaceutical-grade cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. Yet, for over seven years, the DEA has obstructed MMJ's efforts through unconstitutional administrative proceedings, arbitrary quotas, and a bureaucratic "Catch-22" that demands documentation (BFSA) which is unattainable without the very registration the DEA refuses to grant. A Constitutional Crisis Exposed The Supreme Court's rulings in Axon v. FTC and Jarkesy v. SEC have now exposed the DEA's internal administrative law judge (ALJ) system as an unconstitutional charade. Despite this, DEA legal counsel Aarathi Haig continues to defend a system the Department of Justice has now abandoned. Former Chief ALJ John "McLooney" Mulrooney has since retired, leaving behind what critics call a "legal dumpster fire." MMJ's legal exceptions, filed July 3, 2025, detail the agency's structural bias, retroactive sabotage, and deliberate obstruction of medical research. "We followed every law, built the FDA-inspected facility, and secured our clinical approvals," said Duane Boise, CEO of MMJ International Holdings. "What the DEA calls regulation is nothing more than bureaucratic revenge." The Time for Reckoning is Now With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. This demands immediate action: Fire entrenched obstructionists like Thomas Prevoznik. Investigate Aarathi Haig for perpetuating unconstitutional legal processes. Transfer oversight of cannabis research to the FDA, where science-not sabotage-will guide policy. "The DEA has spent a decade fortifying a broken system that protects monopolies, obstructs innovation, and ignores public safety disasters like the Assured Testing Labs scandal in Massachusetts," said Boise. "America doesn't need another anti-marijuana crooner in a suit-it needs a leader who will stand up to this agency's sabotage and put patients first." MMJ International Holdings remains committed to factual accuracy and will continue to expose systemic failures that endanger patients, stifle science, and betray the public trust. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So should INOVIQ (ASX:IIQ) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Let's start with an examination of the business' cash, relative to its cash burn. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. How Long Is INOVIQ's Cash Runway? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at December 2024, INOVIQ had cash of AU$9.5m and no debt. Looking at the last year, the company burnt through AU$4.7m. That means it had a cash runway of about 2.0 years as of December 2024. Arguably, that's a prudent and sensible length of runway to have. You can see how its cash balance has changed over time in the image below. View our latest analysis for INOVIQ How Well Is INOVIQ Growing? On balance, we think it's mildly positive that INOVIQ trimmed its cash burn by 17% over the last twelve months. But the revenue dip of 17% in the same period was a bit concerning. In light of the data above, we're fairly sanguine about the business growth trajectory. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years. How Easily Can INOVIQ Raise Cash? Even though it seems like INOVIQ is developing its business nicely, we still like to consider how easily it could raise more money to accelerate growth. Companies can raise capital through either debt or equity. Many companies end up issuing new shares to fund future growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn. Since it has a market capitalisation of AU$44m, INOVIQ's AU$4.7m in cash burn equates to about 11% of its market value. As a result, we'd venture that the company could raise more cash for growth without much trouble, albeit at the cost of some dilution. So, Should We Worry About INOVIQ's Cash Burn? Even though its falling revenue makes us a little nervous, we are compelled to mention that we thought INOVIQ's cash runway was relatively promising. While we're the kind of investors who are always a bit concerned about the risks involved with cash burning companies, the metrics we have discussed in this article leave us relatively comfortable about INOVIQ's situation. Taking a deeper dive, we've spotted 5 warning signs for INOVIQ you should be aware of, and 1 of them makes us a bit uncomfortable. Of course INOVIQ may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data